Type 2 Diabetes: Diagnosis and Current Guidelines for Treatment

In the 25 years since its emergence in the US, West Nile virus has become the leading cause of domestic mosquito-borne disease. It causes approximately 1300 neuroinvasive disease cases and 130 deaths annually in the US. Coauthor Carolyn Gould, MD, of the CDC joins JAMA Senior Editor Karen Lasser, MD, to discuss the review on this topic published in JAMA. Related Content: West Nile Virus What Is West Nile Virus Infection? ----------------------------------- JAMA Editors' Summary

Worldwide, 1 in 3 women and 1 in 5 men older than 50 years experience osteoporotic fractures in their lifetime. Author Suzanne N. Morin, MD, MSc, of McGill University and JAMA Deputy Editor Mary M. McDermott, MD, discuss the diagnosis and management of osteoporosis. Related Content: Osteoporosis

Which tests can be used to diagnose type 2 diabetes? When should injectable medications for type 2 diabetes be started? These are just some of the questions clinicians may have when diagnosing and treating type 2 diabetes in adults. Author Rita Kalyani, MD, MHS, of Johns Hopkins University School of Medicine, discusses this and more with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content: Diagnosis and Treatment of Type 2 Diabetes in Adults

Adrenal insufficiency is a syndrome of cortisol deficiency. A recent JAMA Review summarizes the pathophysiology, diagnosis, and treatment of adrenal insufficiency and adrenal crisis. JAMA Associate Editor David Simel, MD, MHS, discusses this and more with author Anand Vaidya, MD, MMSc. Related Content: Adrenal Insufficiency in Adults

Interview with Anne P. Cameron, MD and Glenn T. Werneburg, MD, PhD, authors of Foley Catheter Management: A Review. Hosted by Amalia Cochran, MD. Related Content: Foley Catheter Management

Patients' treatment expectations may affect their treatment outcomes. Coauthor Johannes A. C. Laferton, PhD, joins JAMA Senior Editor Anne Cappola, MD, ScM, to discuss the latest article in JAMA's Communicating Medicine series, which explores how to help patients have a better experience and better outcomes with treatment. Related Content: Improving Patients’ Treatment Expectations

Elevated levels of lipoprotein(a) are associated with higher rates of cardiovascular events. Author Samia Mora, MD, MHS, of Brigham and Women’s Hospital and Harvard Medical School discusses measurement and interpretation of lipoprotein (a) levels with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Lipoprotein(a)

A central question in platelet transfusion is whether to follow a restrictive or liberal strategy in decisions about which patients should receive platelets. Author Ryan Metcalf, MD, University of Utah, discusses new clinical guidelines for platelet transfusion and more with JAMA Executive Editor Gregory Curfman, MD. Related Content: Platelet Transfusion Red Blood Cell Transfusion in the Intensive Care Unit Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care Red Blood Cell Transfusion Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014

Immune thrombotic thrombocytopenic purpura (iTTP) is a rare coagulopathic disorder characterized by immune-mediated thrombocytopenia and microangiopathic hemolytic anemia, that can cause life-threatening thrombosis. Coauthor Allyson M. Pishko, MD, MSCE, of the University of Pennsylvania joins JAMA Associate Editor David Simel, MD, MHS, to discuss the recent review of iTTP published in JAMA. Related Content: Immune Thrombotic Thrombocytopenic Purpura

The human microbiome appears to influence risk for development and progression of cancer and response to treatment. Author Jennifer Wargo, MD, University of Texas M.D. Anderson Cancer Center, discusses basic science and clinical evidence regarding the human microbiome and cancer risk with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: The Microbiome and Cancer